Rep. Matthew Hill's Campaign Ads: Radio Spot "Voice Overs" By Leitner (Gregory) Pharmaceuticals Lobbyist?
I began noticing this Monday morning (October 2, 2006) that Rep. Matthew Hill's 2006 re-election campaign radio advertising on WHFG 92.FM is featuring a narrator doing the "voice overs" and sounding amazingly similar to former Tennessee Senator and Leitner Pharmaceuticals lobbyist Jim Holcomb. Holcomb at one time happened a WPWT 870 AM guest co-host of the "Rightly Speaking" morning talk radio program.
Holcomb was previously hired by former King Pharmaceuticals, Inc. CEO John M. Gregory as a lobbyist with King Pharmaceuticals, with the former Tennessee state senator's most noteable post-Tennessee General Assembly lobbying effort was that being his famed August 1999 King legislative "Airlift For Altace" of several legislators from Northeast Tennessee (including Senator Ron Ramsey and Representatives David Davis and Steve Godsey) to a Nashville meeting with the then TennCare Director Brian Lapps. Holcomb's 1999 Altace lobbying effort using King corporate aircraft secured Director Lapps' placement of Monarch Pharmaceuticals --- a King Pharmaceuticals subsidiary --- newly acquired and branded Altace cardiac prescription drug onto the TennCare Preferred Drug List (PDL).
Monarch Pharmaceuticals' branded Altace prescription drug was added to the TennCare PDL within approximately 30 days --- and very close to the date of Director Lapps' late September 1999 resignation as TennCare Director.
King Pharmaceuticals (d.b.a. Monarch Pharmaceuticals) had just previously acquired the U.S. distribution and marketing rights to Altace and other Hoechst products after completing late December 1998 negotiations with Hoechst AG of Germany and the Hoechst American subsidiary Hoechst Marrion Roussell (HMR of Kansas City, Missouri). Former King Pharmaceuticals President Jefferson "Jeff" Gregory (brother of then King Pharmaceuticals CEO John M. Gregory) started Altace acquisition negotiations with Hoechst/HMR during the summer of 1995.
Altace was among several HMR prescription drugs that were central among the economic boycott targets at Hoechst/HMR selected by various nationwide anti-RU86 abortion rights groups (such as Pharmacists For Life International) at the beginning of the 1994 National Right To Life Committee Boycott of Hoechst/MHR. A French pharmaceutcial subsidairy of Hoechst developed and sold the RU-486 abortion drug outsideof the United States.
The another effect of the Monarch acquistion of Altace by the Gregorys was that of allowing Hoechst/HMR to circumvent the U.S. market obstacles that Hoechst/HMR encountered while attempting to selling Altace and other Hoechst/HMR drugs to American puchasers during the National Right To Life Committee Boycott by forming an interdependent business relationship between Monarch and Hoechst/HMR.
Holcomb is also listed as the treasurer of John M. Gregory's Tennessee Conservative PAC.
Holcomb was previously hired by former King Pharmaceuticals, Inc. CEO John M. Gregory as a lobbyist with King Pharmaceuticals, with the former Tennessee state senator's most noteable post-Tennessee General Assembly lobbying effort was that being his famed August 1999 King legislative "Airlift For Altace" of several legislators from Northeast Tennessee (including Senator Ron Ramsey and Representatives David Davis and Steve Godsey) to a Nashville meeting with the then TennCare Director Brian Lapps. Holcomb's 1999 Altace lobbying effort using King corporate aircraft secured Director Lapps' placement of Monarch Pharmaceuticals --- a King Pharmaceuticals subsidiary --- newly acquired and branded Altace cardiac prescription drug onto the TennCare Preferred Drug List (PDL).
Monarch Pharmaceuticals' branded Altace prescription drug was added to the TennCare PDL within approximately 30 days --- and very close to the date of Director Lapps' late September 1999 resignation as TennCare Director.
King Pharmaceuticals (d.b.a. Monarch Pharmaceuticals) had just previously acquired the U.S. distribution and marketing rights to Altace and other Hoechst products after completing late December 1998 negotiations with Hoechst AG of Germany and the Hoechst American subsidiary Hoechst Marrion Roussell (HMR of Kansas City, Missouri). Former King Pharmaceuticals President Jefferson "Jeff" Gregory (brother of then King Pharmaceuticals CEO John M. Gregory) started Altace acquisition negotiations with Hoechst/HMR during the summer of 1995.
Altace was among several HMR prescription drugs that were central among the economic boycott targets at Hoechst/HMR selected by various nationwide anti-RU86 abortion rights groups (such as Pharmacists For Life International) at the beginning of the 1994 National Right To Life Committee Boycott of Hoechst/MHR. A French pharmaceutcial subsidairy of Hoechst developed and sold the RU-486 abortion drug outsideof the United States.
The another effect of the Monarch acquistion of Altace by the Gregorys was that of allowing Hoechst/HMR to circumvent the U.S. market obstacles that Hoechst/HMR encountered while attempting to selling Altace and other Hoechst/HMR drugs to American puchasers during the National Right To Life Committee Boycott by forming an interdependent business relationship between Monarch and Hoechst/HMR.
Holcomb is also listed as the treasurer of John M. Gregory's Tennessee Conservative PAC.
posted by Elmer Gantry at
12:44 PM
1 Comments:
It should also be noted that Holcomb is also a co-chair for the David Davis 1st Congressional District campaign team.
Post a Comment
Subscribe to Post Comments [Atom]
<< Home